Back to Rare Disease
NCT00016445
NCT00016445
Who may be able to join
Who might be able to join this trial:
- The patient must have cystic fibrosis and not yet have gone through puberty
- The patient must be able to perform breathing tests (lung function tests)
- The patient must be significantly below the normal height and/or weight for their age and sex (less than 25% of the normal range)
Who may not be able to join:
- People whose lungs are colonized with a specific type of bacteria called Burkholderia cepacia
- People who need insulin or have ever needed insulin
- People with a blood or bone marrow disease
- People with liver disease
- People with kidney disease
- People who have diabetes or have had diabetes in the past
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Trial details
Status
Completed
Phase
Phase 2
Sponsor
University of Utah
Registry
clinicaltrials_gov
Start date
1 February 2001
Est. completion
1 August 2007
Where this trial is recruiting
🇺🇸 United States
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.